跳至主要内容
临床试验/CTRI/2024/07/070444
CTRI/2024/07/070444尚未招募3 期

An interventional study to evaluate the efficacy and safety of topical metformin in the treatment of melasma at a tertiary care center

Anu Sarah Philip1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年7月22日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Percentage of patients with reduction in modified melasma area and severity index

研究概览

简要总结

This is an interventional study to evaluate the efficacy and safety of topical metformin cream once daily in treating 30 patients with melasma for 12 weeks that will be conducted in a single tertiary care centre in India. The primary outcome measure will be percentage of patients with reduction in modified melasma area and severity index score at 12 weeks . The secondary outcomes will be the percentage of patients with reduction in dermoscopy score and increase in patient satisfaction score at 12 weeks

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • ADULT MALES OR FEMALES WITH A CLINICAL DIAGNOSIS OF MELASMA.

排除标准

  • Age less than 18 years or more than 80 years.
  • Patients with a history of photosensitivity disorders.
  • Patients on medications known to cause hyperpigmentation or photosensitivity.
  • Patients on immunosuppressants .
  • Patients with facial pigmentation caused by conditions other than melasma.

结局指标

主要结局

Percentage of patients with reduction in modified melasma area and severity index

时间窗: 12 weeks

次要结局

  • Percentage of patients with reduction in dermoscopy score(12 weeks)
  • Percentage of patients with increase in patient satisfaction scale.(12 weeks)

研究者

发起方
Anu Sarah Philip
申办方类型
Other [PRINCIPAL INVESTIGATOR]
责任方
Principal Investigator
主要研究者

Anu Sarah Philip

Bangalore Medical College and Research Institute

研究点 (1)

Loading locations...

相似试验